Germany Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

February 2024 | 48 pages | ID: G56611048C6DEN
MarketLine

Abstracts

Germany Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Summary

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
• The German biotechnology market recorded revenues of $29.4 billion in 2023, representing a compound annual growth rate (CAGR) of 41.8% between 2018 and 2023.
• The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $27 billion, equivalent to 92% of the market's overall value.
• The German biotechnology market is experiencing growth due to innovation and the potential for significant therapeutic developments. Germany's biotechnology market is focusing on research and development, with numerous businesses investing in this field. For instance, in April 2023, Boehringer Ingelheim opened its new Biologicals Development Centre in Biberach a der RiЯ, Germany, with R&D financing totaling EUR350 million ($413.9 million), marking the company's largest single investment in Germany to date.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons to Buy

• What was the size of the Germany biotechnology market by value in 2023?
• What will be the size of the Germany biotechnology market in 2028?
• What factors are affecting the strength of competition in the Germany biotechnology market?
• How has the market performed over the last five years?
• What are the main segments that make up Germany's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?

8 COMPANY PROFILES

8.1. Bayer AG
8.2. Boehringer Ingelheim GmbH
8.3. Merck & Co., Inc.
8.4. BioNTech SE

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Germany biotechnology industry value: $ million, 2018-23
Table 2: Germany biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: Germany biotechnology industry category segmentation: $ million, 2018-2023
Table 4: Germany biotechnology industry geography segmentation: $ million, 2023
Table 5: Germany biotechnology industry value forecast: $ million, 2023-28
Table 6: Bayer AG: key facts
Table 7: Bayer AG: Annual Financial Ratios
Table 8: Bayer AG: Key Employees
Table 9: Bayer AG: Key Employees Continued
Table 10: Boehringer Ingelheim GmbH: key facts
Table 11: Boehringer Ingelheim GmbH: Key Employees
Table 12: Merck & Co., Inc.: key facts
Table 13: Merck & Co., Inc.: Annual Financial Ratios
Table 14: Merck & Co., Inc.: Key Employees
Table 15: Merck & Co., Inc.: Key Employees Continued
Table 16: BioNTech SE: key facts
Table 17: BioNTech SE: Annual Financial Ratios
Table 18: BioNTech SE: Key Employees
Table 19: Germany size of population (million), 2019-23
Table 20: Germany gdp (constant 2005 prices, $ billion), 2019-23
Table 21: Germany gdp (current prices, $ billion), 2019-23
Table 22: Germany inflation, 2019-23
Table 23: Germany consumer price index (absolute), 2019-23
Table 24: Germany exchange rate, 2019-23

List Of Figures

LIST OF FIGURES

Figure 1: Germany biotechnology industry value: $ million, 2018-23
Figure 2: Germany biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: Germany biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in Germany, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2023